236 related articles for article (PubMed ID: 21771727)
1. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract][Full Text] [Related]
2. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.
Yang Z; Li DM; Xie Q; Dai DQ
J Cancer Res Clin Oncol; 2015 Feb; 141(2):211-20. PubMed ID: 25156819
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.
Smith LT; Lin M; Brena RM; Lang JC; Schuller DE; Otterson GA; Morrison CD; Smiraglia DJ; Plass C
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):982-7. PubMed ID: 16415157
[TBL] [Abstract][Full Text] [Related]
4. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
[TBL] [Abstract][Full Text] [Related]
5. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
Zhang H; Guo Y; Shang C; Song Y; Wu B
Urology; 2012 Dec; 80(6):1298-302.e1. PubMed ID: 23206776
[TBL] [Abstract][Full Text] [Related]
6. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
Weiss D; Stockmann C; Schrödter K; Rudack C
Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
[TBL] [Abstract][Full Text] [Related]
7. [Over-expression of transcription factor 21 inhibits the proliferation and migration and promotes apoptosis of SMMC-7721 cells].
Tan J; Zhang G; Liu R; Zhou M; Li Z; Wu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):884-8. PubMed ID: 26146055
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.
Richards KL; Zhang B; Sun M; Dong W; Churchill J; Bachinski LL; Wilson CD; Baggerly KA; Yin G; Hayes DN; Wistuba II; Krahe R
Cancer; 2011 Feb; 117(3):606-17. PubMed ID: 20945327
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of KISS1 as a novel target of Let-7i in melanoma serves as a potential suppressor of migration and proliferation in vitro.
Alkafaji HA; Raji A; Rahman HS; Zekiy AO; Adili A; Jalili M; Hojjatipour T; Cid-Arregui A; Shomali N; Tarzi S; Tamjidifar R; Heshmati R; Marofi F; Akbari M; Hasanzadeh A; Deljavanghodrati M; Jarahian M; Sandoghchian Shotorbani S
J Cell Mol Med; 2021 Jul; 25(14):6864-6873. PubMed ID: 34096173
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
12. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
13. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
Gooskens SL; Klasson TD; Gremmels H; Logister I; Pieters R; Perlman EJ; Giles RH; van den Heuvel-Eibrink MM
Mol Oncol; 2018 Feb; 12(2):166-179. PubMed ID: 29080283
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ
PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788
[TBL] [Abstract][Full Text] [Related]
15. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.
Nash KT; Phadke PA; Navenot JM; Hurst DR; Accavitti-Loper MA; Sztul E; Vaidya KS; Frost AR; Kappes JC; Peiper SC; Welch DR
J Natl Cancer Inst; 2007 Feb; 99(4):309-21. PubMed ID: 17312308
[TBL] [Abstract][Full Text] [Related]
16. TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney.
Gooskens SL; Gadd S; Guidry Auvil JM; Gerhard DS; Khan J; Patidar R; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Mullighan CG; Ma J; Jennings LJ; de Krijger RR; van den Heuvel-Eibrink MM; Smith MA; Ross N; Gastier-Foster JM; Perlman EJ
Oncotarget; 2015 Jun; 6(18):15828-41. PubMed ID: 26158413
[TBL] [Abstract][Full Text] [Related]
17. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
18. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
[TBL] [Abstract][Full Text] [Related]
19. Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development.
Ichi S; Costa FF; Bischof JM; Nakazaki H; Shen YW; Boshnjaku V; Sharma S; Mania-Farnell B; McLone DG; Tomita T; Soares MB; Mayanil CS
J Biol Chem; 2010 Nov; 285(47):36922-32. PubMed ID: 20833714
[TBL] [Abstract][Full Text] [Related]
20. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
